Robotic Prostate Cancer Surgery Performed On Two Brothers, Just Hours Apart

Main Category: Medical Devices / Diagnostics
Also Included In: Prostate / Prostate Cancer;  Urology / Nephrology
Article Date: 18 Jan 2008 - 4:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

"We are blessed to have each other to depend on. If you have to go through something bad like cancer, you're glad to have a friend to go through it with," said one of two brothers from Savannah, Georgia recovering from robotic prostate cancer surgery. The two siblings flew to The Mount Sinai Medical Center in New York to have lifesaving surgery on the same day this week. Dr. David B. Samadi, M.D., Chief of Robotics and Minimally Invasive Surgery in the Department of Urology at Mount Sinai successfully performed the robotic prostate cancer surgeries on the siblings one after another on Monday, January 14th, 2008.

"The brothers have benefited physically and even emotionally as a result of having their prostatectomy with the da Vinci robotic technology at Mount Sinai together," said Dr. Samadi. "Each minimally invasive surgery was an hour and twenty minutes which included only a few tiny incisions, limited blood loss (50 CC), no need for blood transfusions, less pain, and a faster recovery which included each of the patients walking the next day and were released from the hospital two days after surgery."

Also, along with the help of Microvascular and Plastic Surgeon Dr. Jess Ting, M.D. of the Department of Surgery, the doctors were able to preserve each patient's sexual function after robotic surgery by implanting a nerve graft extracted from each patient's leg. "I will still be a normal person after robotic surgery, with feeling of all nerves because of the graft," said one brother.

"Just little holes" described the two brothers of their minor incisions from surgery, who both are grateful to have had the opportunity and option to have minimally invasive robotic prostate cancer surgery at Mount Sinai and avoiding open surgery. "Cancer is always a matter of life and death, that's why we chose Mount Sinai for robotic prostate cancer surgery." The brothers who are now patients turned advocates have advice for other men about prostate cancer, "When you're talking about cancer, you can't take any chance. We know some people are scared to have a PSA test but its so minor- you need to get checked. If ours was not tested we would be dead."

----------------------------
Article adapted by Medical News Today from original press release.
----------------------------

About Dr. Samadi

Dr. Samadi is one of the very few urologic surgeons in the United States, who is trained both in oncology and robotic surgery. To date, Dr. Samadi has performed over 800 robotic prostate surgeries, and the results are very pleasing for his patients. Dr. Samadi is a board-certified urologist and a specialist in the diagnosis and treatment of urologic diseases, kidney cancer, bladder cancer, and prostate cancer. He is a leader in prostate cancer treatment and robotic prostate surgery using the da Vinci surgery system.

Dr. Samadi is one of few surgeons in the United States trained in all three fields of urologic surgery including open, laparoscopic, and da Vinci robotics. David B. Samadi, M.D., uses the da Vinci robotic surgery system for the remedy of prostate, bladder, and kidney cancers. He specializes in prostate cancer treatment and prostate surgery.

For more information about Dr. Samadi visit: http://www.roboticoncology.com/.

About The Mount Sinai Medical Center

The Mount Sinai Medical Center encompasses The Mount Sinai Hospital and Mount Sinai School of Medicine. The Mount Sinai Hospital is one of the nation's oldest, largest and most-respected voluntary hospitals. Founded in 1852, Mount Sinai today is a 1,171-bed tertiary-care teaching facility that is internationally acclaimed for excellence in clinical care. Last year, nearly 50,000 people were treated at Mount Sinai as inpatients, and there were nearly 450,000 outpatient visits to the Medical Center.

Mount Sinai School of Medicine is internationally recognized as a leader in groundbreaking clinical and basic-science research, as well as having an innovative approach to medical education. With a faculty of more than 3,400 in 38 clinical and basic science departments and centers, Mount Sinai ranks among the top 20 medical schools in receipt of National Institute of Health (NIH) grants.

Source: Mount Sinai Newsroom
The Mount Sinai Hospital / Mount Sinai School of Medicine